Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
Papp, Kim A, Blauvelt, Andrew, Bukhalo, Michael, Gooderham, Melinda, Krueger, James, Lacour, Jean-Philippe, Menter, Alan, Philipp, Sandra, Sofen, Howard, Tyring, Stephen, Berner, Beate R, Visvanathan, Sudha, Pamulapati, Chandrasena, Bennett, Nathan, Flack, Mary, Scholl, Paul, Padula, Steven J
Published in The New England journal of medicine (20.04.2017)
Published in The New England journal of medicine (20.04.2017)
Get full text
Journal Article
Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study
Jimenez, Pablo A., Sofen, Howard L., Bissonnette, Robert, Lee, Mark, Fowler, Joseph, Zammit, David J., Chen, Yusong, Rao, Niranjan, Denis, Louis, Gupta, Sandeep
Published in Journal of the American Academy of Dermatology (01.08.2023)
Published in Journal of the American Academy of Dermatology (01.08.2023)
Get full text
Journal Article
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
Thaçi, Diamant, Prof, Simpson, Eric L, MD, Beck, Lisa A, Prof, Bieber, Thomas, Prof, Blauvelt, Andrew, MD, Papp, Kim, MD, Soong, Weily, MD, Worm, Margitta, Univ-Prof, Szepietowski, Jacek C, Prof, Sofen, Howard, MD, Kawashima, Makoto, Prof, Wu, Richard, PhD, Weinstein, Steven P, MD, Graham, Neil M H, MD, Pirozzi, Gianluca, MD, Teper, Ariel, MD, Sutherland, E Rand, MD, Mastey, Vera, MS, Stahl, Neil, PhD, Yancopoulos, George D, MD, Ardeleanu, Marius, MD
Published in The Lancet (British edition) (02.01.2016)
Published in The Lancet (British edition) (02.01.2016)
Get full text
Journal Article
Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis
Sofen, Howard, MD, Smith, Stacy, MD, Matheson, Robert T., MD, Leonardi, Craig L., MD, Calderon, Cesar, PhD, Brodmerkel, Carrie, PhD, Li, Katherine, MS, Campbell, Kim, PhD, Marciniak, Stanley J., MBA, Wasfi, Yasmine, MD, PhD, Wang, Yuhua, PhD, Szapary, Philippe, MD, Krueger, James G., MD, PhD
Published in Journal of allergy and clinical immunology (01.04.2014)
Published in Journal of allergy and clinical immunology (01.04.2014)
Get full text
Journal Article
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study
Gebauer, Kurt, Spelman, Lynda, Yamauchi, Paul S., Bagel, Jerry, Nishandar, Tushar, Crane, Michael, Kopeloff, Iris, Kothekar, Mudgal, Yao, Siu-Long, Sofen, Howard L.
Published in Journal of the American Academy of Dermatology (01.07.2024)
Published in Journal of the American Academy of Dermatology (01.07.2024)
Get full text
Journal Article
Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
Sharpe, Hayley J., Pau, Gregoire, Dijkgraaf, Gerrit J., Basset-Seguin, Nicole, Modrusan, Zora, Januario, Thomas, Tsui, Vickie, Durham, Alison B., Dlugosz, Andrzej A., Haverty, Peter M., Bourgon, Richard, Tang, Jean Y., Sarin, Kavita Y., Dirix, Luc, Fisher, David C., Rudin, Charles M., Sofen, Howard, Migden, Michael R., Yauch, Robert L., de Sauvage, Frederic J.
Published in Cancer cell (09.03.2015)
Published in Cancer cell (09.03.2015)
Get full text
Journal Article
Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial
Papp, Kim, Dr, Cather, Jennifer C, MD, Rosoph, Les, MD, Sofen, Howard, MD, Langley, Richard G, MD, Matheson, Robert T, MD, Hu, ChiaChi, EdM, Day, Robert M, PhD
Published in The Lancet (British edition) (25.08.2012)
Published in The Lancet (British edition) (25.08.2012)
Get full text
Journal Article
A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma
Sofen, Howard, MD, Gross, Kenneth G., MD, Goldberg, Leonard H., MD, FRCP, Sharata, Harry, MD, PhD, Hamilton, Tiffani K., MD, Egbert, Barbara, MD, Lyons, Benjamin, PhD, Hou, Jeannie, MD, Caro, Ivor, MD
Published in Journal of the American Academy of Dermatology (01.07.2015)
Published in Journal of the American Academy of Dermatology (01.07.2015)
Get full text
Journal Article
The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study
Gottlieb, Alice B., MD, PhD, Kalb, Robert E., MD, Blauvelt, Andrew, MD, Heffernan, Michael P., MD, Sofen, Howard L., MD, Ferris, Laura Korb, MD, PhD, Kerdel, Francisco A., MD, Calabro, Stephen, MS, Wang, Jim, PhD, Kerkmann, Urs, MD, Chevrier, Marc, MD, PhD
Published in Journal of the American Academy of Dermatology (01.10.2012)
Published in Journal of the American Academy of Dermatology (01.10.2012)
Get full text
Journal Article
Perspectives on Living with Chronic Spontaneous Urticaria: From Onset through Diagnosis and Disease Management in the US
Goldstein, Stanley, Eftekhari, Sanaz, Mitchell, Lynda, Winders, Tonya A, Kaufman, Leslie, Dudas, Debra, Paknis, Brandee, Kavati, Abhishek, Delwart, Virginie, Sofen, Howard L
Published in Acta dermato-venereologica (01.11.2019)
Published in Acta dermato-venereologica (01.11.2019)
Get full text
Journal Article
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials
Korman, Neil J, Warren, Richard B, Bagel, Jerry, Armstrong, April W, Gooderham, Melinda, Strober, Bruce, Thaçi, Diamant, Morita, Akimichi, Imafuku, Shinichi, Foley, Peter, Sofen, Howard, Zheng, Min, Hippeli, Lauren, Kisa, Renata M, Banerjee, Subhashis, Blauvelt, Andrew
Published in The Journal of dermatological treatment (01.12.2024)
Published in The Journal of dermatological treatment (01.12.2024)
Get full text
Journal Article
Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis
Mohamed, Mohamed‐Eslam F., Qian, Yuli, D'Cunha, Ronilda, Sligh, Teresa, Ferris, Laura K., Eldred, Ann, Levy, Gweneth F., Hao, Shuai, Gannu, Shashikanth, Rizzo, David G., Liu, Wei, Jazayeri, Sasha, Sofen, Howard, Carcereri De Prati, Roberto
Published in Clinical and translational science (01.01.2024)
Published in Clinical and translational science (01.01.2024)
Get full text
Journal Article
Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis
Lio, Peter A., Armstrong, April, Gutermuth, Jan, Nosbaum, Audrey, Sofen, Howard, Gil, Esther Garcia, Casillas, Marta, Chen, Sherry, Sun, Luna, Pierce, Evangeline, Elmaraghy, Hany, Dawson, Zach, Torres, Tiago
Published in Dermatology and therapy (01.07.2024)
Published in Dermatology and therapy (01.07.2024)
Get full text
Journal Article
Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trial
Kalb, Robert E, Blauvelt, Andrew, Sofen, Howard L, Chevrier, Marc, Amato, David, Calabro, Stephen, Wang, Jim, Schenkel, Brad, Gottlieb, Alice B
Published in Journal of drugs in dermatology (01.08.2013)
Get more information
Published in Journal of drugs in dermatology (01.08.2013)
Journal Article
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
Gordon, Kenneth B, Strober, Bruce, Lebwohl, Mark, Augustin, Matthias, Blauvelt, Andrew, Poulin, Yves, Papp, Kim A, Sofen, Howard, Puig, Lluís, Foley, Peter, Ohtsuki, Mamitaro, Flack, Mary, Geng, Ziqian, Gu, Yihua, Valdes, Joaquin M, Thompson, Elizabeth H Z, Bachelez, Hervé
Published in The Lancet (British edition) (25.08.2018)
Published in The Lancet (British edition) (25.08.2018)
Get full text
Journal Article
Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT)
Lebwohl, Mark, Blauvelt, Andrew, Paul, Carle, Sofen, Howard, Węgłowska, Jolanta, Piguet, Vincent, Burge, Daniel, Rolleri, Robert, Drew, Janice, Peterson, Luke, Augustin, Matthias
Published in Journal of the American Academy of Dermatology (01.08.2018)
Published in Journal of the American Academy of Dermatology (01.08.2018)
Get full text
Journal Article
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial
Strober, Bruce, Thaçi, Diamant, Sofen, Howard, Kircik, Leon, Gordon, Kenneth B., Foley, Peter, Rich, Phoebe, Paul, Carle, Bagel, Jerry, Colston, Elizabeth, Throup, John, Kundu, Sudeep, Sekaran, Chitra, Linaberry, Misti, Banerjee, Subhashis, Papp, Kim A.
Published in Journal of the American Academy of Dermatology (01.01.2023)
Published in Journal of the American Academy of Dermatology (01.01.2023)
Get full text
Journal Article
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
Simpson, Eric L., Flohr, Carsten, Eichenfield, Lawrence F., Bieber, Thomas, Sofen, Howard, Taïeb, Alain, Owen, Ryan, Putnam, Wendy, Castro, Marcela, DeBusk, Kendra, Lin, Chin-Yu, Voulgari, Athina, Yen, Karl, Omachi, Theodore A.
Published in Journal of the American Academy of Dermatology (01.05.2018)
Published in Journal of the American Academy of Dermatology (01.05.2018)
Get full text
Journal Article
51480 Efficacy of apremilast in adults with mild-to-moderate plaque psoriasis with scalp involvement: Pooled data from PROMINENT, ADVANCE, and EMBRACE trials
Gold, Linda Stein, Augustin, Matthias, Sofen, Howard, Gisondi, Paolo, Jardon, Shauna, Reddy, Jyotsna, Zou, Henry, Duffin, Kristina Callis
Published in Journal of the American Academy of Dermatology (01.09.2024)
Published in Journal of the American Academy of Dermatology (01.09.2024)
Get full text
Journal Article
Sustained Improvement in UAS7 After 16-Week Treatment With Tezepelumab in Biologic-Naïve Adults with CSU: Results of the Phase 2b INCEPTION Study
Maurer, Marcus, McLaren, Julie, Chon, Yun, Gorski, Kevin, Bernstein, Jonathan, Hayama, Koremasa, Jain, Vipul, Sofen, Howard, Ponnarambil, Sandhia, Molfino, Nestor
Published in Journal of allergy and clinical immunology (01.02.2024)
Published in Journal of allergy and clinical immunology (01.02.2024)
Get full text
Journal Article